MYNZ Stock Earnings: Mainz Biomed Beats EPS, Misses Revenue for Q4 2023

    Date:

    Mainz Biomed (NASDAQ:MYNZ) just reported results for the fourth quarter of 2023.

    • Mainz Biomed reported earnings per share of -24 cents. This was above the analyst estimate for EPS of -32 cents.
    • The company reported revenue of $214,761.
    • This was 20.46% worse than the analyst estimate for revenue of $270,000.

    InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com.

    Go Source

    Chart

    SignUp For Breaking Alerts

    New Graphic

    We respect your email privacy

    Share post:

    Popular

    More like this
    Related

    What It Takes to Win Elections, According to Former Canadian PM Stephen Harper

    Last week, at the North American Blockchain Summit in...

    Midstream’s Goldilocks Phase

    The word of the week is re-rating. Both Wells Fargo...

    What are the national debt and deficit?

    Key takeaways What is the national debt? The national debt is...

    Chart Advisor: Evaluating NVIDIA

    By Fadi Dawood 1/ NVIDIA ($NVDA): Testing Key Support After Recent...